Kender Richard N bought MCRB
March 4, 2026 · Form 4 insider transaction
Kender Richard N bought 150,000 shares of Seres Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
150,000
Price
$0.00
Total value
N/A
InsiderKender Richard N
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 4, 2026
Filing dateMarch 6, 2026
Shares owned after150,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests and become exercisable in 36 equal monthly installments.